| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
Lynnchem |
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
|
| | Lesinurad Impurity N Basic information |
| Product Name: | Lesinurad Impurity N | | Synonyms: | lesinurad Impurity E: 4-Carboxybutyramide lesinurad;Lesinurad Impurity N;4-[[5-(carboxymethylsulfanyl)-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acid;Butanoic acid, 4-[[5-[(carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo- | | CAS: | 1533519-99-1 | | MF: | C21H20N4O5S | | MW: | 440.47 | | EINECS: | | | Product Categories: | | | Mol File: | 1533519-99-1.mol |  |
| | Lesinurad Impurity N Chemical Properties |
| density | 1.56±0.1 g/cm3(Predicted) | | pka | 2.97±0.10(Predicted) |
| | Lesinurad Impurity N Usage And Synthesis |
| Uses | 4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout. |
| | Lesinurad Impurity N Preparation Products And Raw materials |
|